Levothyroxine suppressive therapy: Harmful and useless or harmless and useful?
- 1 September 1994
- journal article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 17 (8) , 675-677
- https://doi.org/10.1007/bf03349686
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women.Journal of Clinical Endocrinology & Metabolism, 1994
- Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine.Journal of Clinical Endocrinology & Metabolism, 1993
- Morbidity in patients on l‐thyroxine: a comparison of those with a normal TSH to those with a suppressed TSHClinical Endocrinology, 1992
- Long-term thyroxine treatment and bone mineral densityThe Lancet, 1992
- Thyroid Hormone Suppressive Therapy of Sporadic Nontoxic GoiterThyroid®, 1992
- Editorial: Thyroid Hormones and Bone MassJournal of Clinical Endocrinology & Metabolism, 1991
- Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitreThe Lancet, 1990
- Suppressive Therapy with Levothyroxine for Solitary Thyroid NodulesNew England Journal of Medicine, 1987
- Factors Affecting Suppression of Endogenous Thyrotropin Secretion by Thyroxine Treatment: Retrospective Analysis in Athyreotic and Goitrous Patients*Journal of Clinical Endocrinology & Metabolism, 1987
- The Cold Thyroid Nodule: An Analysis of Diagnostic and Therapeutic Options*Endocrine Reviews, 1984